.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Poster
P 095

Pan-serotype dengue virus inhibitor JNJ-A07 targets the NS4A-2K-NS4B interaction with NS2B/NS3 and blocks de novo formation of replication organelles

Appointment

Date: 25/03/2024

Time: 13:00 – 13:00

Talk time: 0 Min.

Discussion time: 0 Min.

Location / Stream:

Antiviral therapy and resistance

Session

Antiviral therapy and resistance

Topic

Antiviral therapy and resistance

Authors

Dr. Dominik Kiemel (Heidelberg / DE), Ann-Sophie Kröll (Heidelberg / DE), Dr. Solène Denolly (Heidelberg / DE), Uta Haselmann (Heidelberg / DE), Dr. Lucas Wilken (Hamburg / DE), Dr. Jean-François Bonfanti (Toulouse / FR; Val de Reuil / FR), Dr. Jose Ignacio Andres (Toledo / ES), Dr. Brahma Ghosh (Spring House, PA / US), Dr. Pietro Scaturro (Hamburg / DE), Dr. Marnix Van Loock (Beerse / BE), Dr. Olivia Goethals (Beerse / BE), Professor Ralf Bartenschlager (Heidelberg / DE)